Kurashiki, Japan

Masayuki Inoue

This inventor holds 2 USPTO granted patents. Top assignees: Kuraray Co., Ltd., Taiho Pharmaceutical Company Limited. Active years: 1991-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masayuki Inoue. Retrieved from https://idiyas.com/inventor/masayuki-inoue-osafm2gf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1991-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masayuki Inoue: Innovator in Anti-Inflammatory Research

Introduction

Masayuki Inoue is a notable inventor based in Kurashiki, Japan. He has made significant contributions to the field of anti-inflammatory research, holding a total of 2 patents. His work focuses on developing innovative compositions that exhibit remarkable efficacy in treating inflammation.

Latest Patents

Inoue's latest patents include the development of 11-beta, 17-alpha, 21-trihydroxy-1,4-pregnadiene-3,20-dione and its derivatives. These compounds demonstrate excellent anti-inflammatory action while minimizing side effects. The production methods he has developed allow for high selectivity and good yield, making these compositions convenient for practical applications.

Career Highlights

Throughout his career, Inoue has worked with prominent companies such as Kuraray Co., Ltd. and Taiho Pharmaceutical Company Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Inoue has collaborated with notable coworkers, including Yutaka Mizushima and Keiko Hoshi. Their combined efforts have further advanced the research and development of anti-inflammatory treatments.

Conclusion

Masayuki Inoue's contributions to anti-inflammatory research and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to impact the field positively, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…